344 related articles for article (PubMed ID: 20979172)
1. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A
Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172
[TBL] [Abstract][Full Text] [Related]
2. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
[TBL] [Abstract][Full Text] [Related]
3. Allosensitization in patients receiving multiple blood transfusions.
Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
[TBL] [Abstract][Full Text] [Related]
4. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Ameen R; Al Shemmari S; Al-Bashir A
Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
[TBL] [Abstract][Full Text] [Related]
7. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
8. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
10. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
12. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
[TBL] [Abstract][Full Text] [Related]
13. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
15. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
Cheng CK; Lee CK; Lin CK
Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation.
Perseghin P; Balduzzi A; Galimberti S; Dassi M; Baldini V; Valsecchi MG; Pioltelli P; Bonanomi S; Faccini P; Rovelli A; Pogliani EM; Uderzo C
Bone Marrow Transplant; 2003 Jul; 32(2):231-6. PubMed ID: 12838290
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients.
Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS
J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
19. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
20. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease.
Tatari-Calderone Z; Minniti CP; Kratovil T; Stojakovic M; Vollmer A; Barjaktarevic I; Zhang E; Hoang A; Luban NL; Vukmanovic S
Mol Immunol; 2009 Nov; 47(1):64-70. PubMed ID: 19201475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
